Analyst Group: Analyst Group Interview Nykode Therapeutics' CEO Michael Engsig
27 augusti, 14:54
27 augusti, 14:54
We have interviewed Michael Engsig, CEO of Nykode Therapeutics. In the interview Michael tell us where the company is today, the strategy going forward and why the company is a good investment.
About Analyst Group: One of the Nordics fastest growing equity research boutiques with a focus on small and medium-sized listed companies.
Read more about Analyst Group (Swedish)
This is a press release from Analyst Group regarding the publication of an interview with Nykode Therapeutics.
27 augusti, 14:54
We have interviewed Michael Engsig, CEO of Nykode Therapeutics. In the interview Michael tell us where the company is today, the strategy going forward and why the company is a good investment.
About Analyst Group: One of the Nordics fastest growing equity research boutiques with a focus on small and medium-sized listed companies.
Read more about Analyst Group (Swedish)
This is a press release from Analyst Group regarding the publication of an interview with Nykode Therapeutics.
Aktieanalys
Emissioner


Aktieanalys
Emissioner


1 DAG %
Senast


OMX Stockholm 30
0,30%
(vid stängning)
Boliden
Igår, 07:00
Kommentar: Ett nytt Boliden
Crowdstrike
28 augusti, 16:49
Cyberaktierna rusar — här är analytikernas favoriter
Rutger Arnhult
28 augusti, 16:01
Rutger Arnhults bolag rapporterar miljardvinst
Alimak
28 augusti, 15:05
Alimak: Kan förvärvet ge lönsamhetslyft?
OMX Stockholm 30
1 DAG %
Senast
3 331,26